PTGS2 and neoplasm: Toll-like receptor 4/9-cyclooxygenase-2 (COX2) signaling [14] and interleukin (IL)-1β/epidermal growth factor receptor (EGFR)/extracellular signal-regulated kinase (ERK) signaling in tumor cells can be activated by NETs [23].